Sitagliptin Vildagliptin And Saxagliptin Dipeptidyl Peptidase 4 Inhibitors Gliptins For Add On Therapy In Type 2 Diabetes Mellitus. Expert opin pharmacother., 2012, 13(1): A review of gliptins in 2011.
He prevalence of type 2 diabetes mellitus (t2dm) is increasing worldwide. Pharmacogenetics of dipeptidyl peptidase 4 inhibitors in a taiwanese population with type 2 diabetes. Clinical data and clinical implications.
Management of hyperglycaemia in type 2 diabetes, 2018.
Clinical data and clinical implications. Pharmacogenetics of dipeptidyl peptidase 4 inhibitors in a taiwanese population with type 2 diabetes. Management of hyperglycaemia in type 2 diabetes, 2018. Clinical data and clinical implications.
Post a Comment for "Sitagliptin Vildagliptin And Saxagliptin Dipeptidyl Peptidase 4 Inhibitors Gliptins For Add On Therapy In Type 2 Diabetes Mellitus"